PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Prostate Cancer · Recurrent Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Contact: Principal Investigator (Kosj Yamoah, M.D., Ph.D.)
Contact: Principal Investigator (Kenneth Gage, M.D., Ph.D.)

Study leads

Kosj Yamoah, M.D., Ph.D.
Principal Investigator
H. Lee Moffitt Cancer Center and Research Institute

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)

Prostate Cancer · Erectile Dysfunction

Abroad (travel likely)RecruitingPHASE3

New York, United States

A Clinical Study of [68Ga]Ga-ELI421 Injection PET Imaging in Patients With Prostate Cancer

Prostate Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Wuhan, China

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Prostate Cancer

IsraelRecruitingPHASE2, PHASE3

Los Angeles, United States · Palo Alto, United States

Prospective Clinical Trial of 177Lu-P17-088 in the Treatment of Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Fuzhou, China